Aromatase inhibitors in ovarian stimulation

Casper, Robert F.

doi:10.1016/j.jsbmb.2007.05.025

Cited by 58 publications

(35 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The blockade of conversion of androgens to estrogens (E) leads to a reduction of serum E levels and suppression of E negative feedback in the brain. Aromatase inhibitors also increase the intrafollicular androgen concentration with a concomitant increase in ovarian follicular FSH receptors (25).…”

mentioning

confidence: 99%

Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination

Bedaiwy

Shokry

Mousa

et al. 2009

Fertility and Sterility

View full text Add to dashboard Cite

mentioning

confidence: 99%

Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination

Bedaiwy

Shokry

Mousa

et al. 2009

Fertility and Sterility

View full text Add to dashboard Cite

“…Letrozole, on the other hand has a shorter duration of action as it does not deplete the oestrogen receptors. Also the shorter half-life of 45 hours helps to minimise the duration of FSH rise [11]. These properties of letrozole would minimise the interruption of the 'FSH threshold' and the 'FSH window' that is seen in physiological states thus preventing multiple follicle development.…”

Section: Discussionmentioning

confidence: 99%

A comparison of endometrial thickness following augmentation of ovulation with clomifene citrate or letrozole in women with ovulatory infertility

2015

View full text Add to dashboard Cite

“…Clomiphene is a selective estrogen receptor modulator that blocks the feedback inhibition of estradiol at the level of the hypothalamus, thus increasing pituitary release of both LH and folliclestimulating hormone (5,21). In addition, clomiphene decreases the conversion of androgen substrate to estrogen by aromatase inhibition (22). It is this ability to block estrogen that leads to its postcycle use by bodybuilders to reduce the development of gynecomastia after self-administration of androgen drugs.…”

Section: Discussionmentioning

confidence: 99%

Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism

Pirola

Cappelli

Delbarba

et al. 2010

Fertility and Sterility

View full text Add to dashboard Cite

Objective: To report a case of hypogonadotropic hypogonadism due to the chronic abuse of anabolic steroids purchased over the Internet. Design: Case report. Setting: Endocrinology unit of the University of Brescia. Patient(s):A 34-year-old man. Intervention(s): A single dose (100 mg) of triptorelin (triptorelin test). Main Outcome Measure(s): Clinical symptoms, androgen normalization, levels of serum testosterone, folliclestimulating hormone, and luteinizing hormone. Result(s): Within 1 month, the patient's serum testosterone was in the normal range, and he reported a return to normal energy and libido. Conclusion(s):The World Anti-Doping Code has proved to be a very powerful and effective tool in the harmonization of antidoping efforts worldwide, but it is insufficient to combat this illegal phenomenon. To tackle the serious side effects caused by doping we believe that it is necessary to increase monitoring and adopt severe sanctions, particularly with regard to Internet sites. (Fertil Steril Ò 2010;94:2331.e1-e3. Ó2010 by American Society for Reproductive Medicine.)Key Words: Anabolic steroids, doping, hypogonadotropic hypogonadism, triptorelin Doping involves the use of artificial means or substances with the specific aim of improving performance, despite well-known adverse effects on health (1). This practice has spread to the general population, in particular to young adults, along with the exaggerated ideals of body image portrayed by the mass media (2-4). Over the last few years, Internet marketing may have played an important role in increasing consumption of anabolic drugs such as anabolic androgen steroids (AAS) and clomiphene citrate (5). We describe the case of a young male with prolonged hypogonadotropic hypogonadism due to ongoing consumption of various doping drugs purchased over the Internet, where they are readily available. CASE REPORTA 34-year-old man presented to our department in September 2008 for loss of libido and energy and for mild depression. He was a computer programmer and a nonprofessional bodybuilder with an unremarkable personal medical history. He admitted to having used doping drugs since he was 21 years old. More specifically, he would perform cycles of intramuscular injections of nandrolone (25 mg) and stanazol (25 mg) daily for 8 weeks, followed by mesterolone (50 mg/day) for 15 days. Then he would then take clomiphene citrate (50 mg/day) for 1 week, followed by an injection of human chorionic gonadotropin (2,000 IU) three times in 1 week. He had repeated these cycles from 1995 to 2005. From 2005 to August 2008, to his nandrolone and stanazol cycle he added an intramuscular injection of boldenone (50 mg) daily for 3 weeks. He said he had bought all the drugs on the Internet.The patient was 175 cm tall and 80 kg, and he appeared very muscular and toned. His blood pressure and pulse rate were normal. Examination of his heart, lungs, and abdomen were likewise unremarkable. The physical examination showed normal secondary sexual characteristics, but the genital examination revea...

show abstract

Aromatase inhibitors in ovarian stimulation

Cited by 58 publications

References 36 publications

Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination

Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination

A comparison of endometrial thickness following augmentation of ovulation with clomifene citrate or letrozole in women with ovulatory infertility

Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism

Contact Info

Product

Resources

About